MedStar Authors catalog › Details for: Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
Normal view MARC view ISBD view

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.

by Weissman, Neil J.
Citation: ; New England Journal of Medicine. 379(12):1107-1117, 2018 09 20..Published: ; 2018ISSN: 0028-4793.Full author list: Bohula EA; Wiviott SD; McGuire DK; Inzucchi SE; Kuder J; Im K; Fanola CL; Qamar A; Brown C; Budaj A; Garcia-Castillo A; Gupta M; Leiter LA; Weissman NJ; White HD; Patel T; Francis B; Miao W; Perdomo C; Dhadda S; Bonaca MP; Ruff CT; Keech AC; Smith SR; Sabatine MS; Scirica BM; CAMELLIA-TIMI 61 Steering Committee and Investigators.UI/PMID: 30145941.Subject(s): Aged | Anti-Obesity Agents/ae [Adverse Effects] | *Anti-Obesity Agents/tu [Therapeutic Use] | Aortic Valve Insufficiency/ci [Chemically Induced] | Benzazepines/ae [Adverse Effects] | *Benzazepines/tu [Therapeutic Use] | Cardiovascular Diseases/ci [Chemically Induced] | *Cardiovascular Diseases/co [Complications] | Cardiovascular Diseases/ep [Epidemiology] | Diabetes Mellitus, Type 2/co [Complications] | Double-Blind Method | Female | Follow-Up Studies | Humans | Hypertension, Pulmonary/ci [Chemically Induced] | *Hypoglycemia/ci [Chemically Induced] | Male | Middle Aged | Obesity/co [Complications] | *Obesity/dt [Drug Therapy] | Overweight/co [Complications] | *Overweight/dt [Drug Therapy] | Risk Factors | *Weight Loss/de [Drug Effects]Institution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Journal ArticleOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1056/NEJMoa1808721 (Click here) Abbreviated citation: ; N Engl J Med. 379(12):1107-1117, 2018 09 20.

Powered by Koha